Dr. Saha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 6th Ave S
Birmingham, AL 35233Phone+1 205-934-9999
Education & Training
Dhaka Medical CollegeClass of 2010
Certifications & Licensure
AL State Medical License 2024 - 2025
NJ State Medical License 2019 - 2023- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha
Haematologica. 2024-11-14 - Recent developments in CD19-targeted therapies for follicular lymphoma.Aditi Saha, Julio C Chavez
Expert Opinion on Biological Therapy. 2024-10-01 - 4 citationsAnti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.Adam S Kittai, David Bond, Ying Huang, Seema A Bhat, Emily Blyth
Journal of Clinical Oncology. 2024-06-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
